Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001168404-22-000004
Filing Date
2022-12-08
Accepted
2022-12-07 20:43:26
Documents
1
Effectiveness Date
2022-12-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12870
  Complete submission text file 0001168404-22-000004.txt   14231
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-465960 | Film No.: 221451271
SIC: 2835 In Vitro & In Vivo Diagnostic Substances